stocks logo

DAWN Financial Analysis

Day One Biopharmaceuticals Inc
$
7.020
-0.200(-2.770%)

DAWN Financial Analysis

FY2024Q4FY2024Q3FY2024Q2FY2024Q1FY2023Q4FY2023Q3FY2023Q2FY2023Q1FY2022Q4FY2022Q3FY2022Q2FY2022Q1FY2021Q4FY2021Q3FY2021Q2FY2021Q1FY2020Q3FY2020Q2FY2020Q1
Total Revenue
29.21M
93.76M
8.19M
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Revenue from Goods & Services
29.21M
93.76M
8.19M
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Goods Sold
2.98M
1.59M
707.00K
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit
26.23M
92.17M
7.49M
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling General & Administrative Expenses
91.56M
53.84%
62.54M
21.57%
122.29M
148.29%
66.77M
45.60%
59.52M
39.24%
51.44M
29.57%
49.25M
34.14%
45.86M
65.26%
42.74M
94.51%
39.70M
106.33%
36.72M
137.83%
27.75M
72.50%
21.98M
19.24M
440.33%
15.44M
568.64%
16.09M
809.33%
3.56M
2.31M
1.77M
Research & Development Expense
61.82M
65.53%
33.56M
1.21%
92.11M
186.20%
40.21M
44.49%
37.35M
43.54%
33.16M
50.50%
32.18M
42.65%
27.83M
85.48%
26.02M
132.55%
22.04M
123.73%
22.56M
127.56%
15.00M
18.77%
11.19M
9.85M
288.21%
9.91M
589.91%
12.63M
1214.46%
2.54M
1.44M
961.00K
Operating Profit
-65.33M
9.77%
29.64M
-157.61%
-114.81M
133.09%
-66.77M
45.60%
-59.52M
39.24%
-51.44M
29.57%
-49.25M
34.14%
-45.86M
65.26%
-42.74M
94.51%
-39.70M
106.33%
-36.72M
137.83%
-27.75M
72.50%
-21.98M
-19.24M
440.33%
-15.44M
568.64%
-16.09M
809.33%
-3.56M
-2.31M
-1.77M
Financing Income- Net
6.05M
20.46%
5.32M
0.59%
3.96M
16.32%
4.37M
25.94%
5.02M
88.87%
5.29M
179.21%
3.41M
1702.12%
3.47M
173200.00%
2.66M
11465.22%
1.90M
-31683.33%
189.00K
-2800.00%
2.00K
-128.57%
23.00K
-6.00K
-33.33%
-7.00K
-30.00%
-7.00K
133.33%
-9.00K
-10.00K
-3.00K
Interest Expense
0.00
0.00
0.00
-100.00%
0.00
0.00
-100.00%
0.00
-100.00%
-3.41M
1702.12%
0.00
-100.00%
-2.66M
11465.22%
-1.90M
-31683.33%
-189.00K
-2800.00%
-2.00K
-128.57%
-23.00K
6.00K
-33.33%
7.00K
-30.00%
7.00K
133.33%
9.00K
10.00K
3.00K
Non-Interest Financial Income
6.05M
20.46%
5.32M
0.59%
3.96M
4.37M
25.94%
5.02M
5.29M
0.00
3.47M
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Non-Operating Income
40.00K
-322.22%
1.20M
-40000.00%
-10.00K
-33.33%
-10.00K
150.00%
-18.00K
-30.77%
-3.00K
-133.33%
-15.00K
-4.00K
300.00%
-26.00K
-285.71%
9.00K
28.57%
0.00
-100.00%
-1,000
-87.50%
14.00K
7.00K
-102.57%
-27.00K
-70.00%
-8.00K
-96.36%
-272.00K
-90.00K
-220.00K
Income before Taxes
-59.24M
8.68%
36.16M
-178.34%
-2.86M
-93.77%
-62.41M
47.22%
-54.51M
35.91%
-46.15M
22.11%
-45.86M
25.55%
-42.39M
52.78%
-40.11M
82.83%
-37.80M
96.44%
-36.53M
136.09%
-27.75M
72.33%
-21.94M
-19.24M
400.78%
-15.47M
542.30%
-16.10M
708.28%
-3.84M
-2.41M
-1.99M
Income Taxes
6.47M
-882.00K
1.55M
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Income after Tax
-65.71M
20.55%
37.04M
-180.25%
-4.41M
-90.39%
-62.41M
47.22%
-54.51M
35.91%
-46.15M
22.11%
-45.86M
25.55%
-42.39M
52.78%
-40.11M
82.83%
-37.80M
96.44%
-36.53M
136.09%
-27.75M
72.33%
-21.94M
-19.24M
400.78%
-15.47M
542.30%
-16.10M
708.28%
-3.84M
-2.41M
-1.99M
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
0.00
-100.00%
98.80M
-15323.88%
-919.00K
101.09%
-1.02M
-649.00K
-457.00K
Income Available to Common Shares
-65.71M
20.55%
37.04M
-180.25%
-4.41M
-90.39%
-62.41M
47.22%
-54.51M
35.91%
-46.15M
22.11%
-45.86M
25.55%
-42.39M
52.78%
-40.11M
82.83%
-37.80M
96.44%
-36.53M
-68.03%
-27.75M
82.76%
-21.94M
-19.24M
581.30%
-114.28M
6392.95%
-15.18M
889.06%
-2.82M
-1.76M
-1.54M
EPS - Basic
-0.64
1.59%
0.38
-170.37%
-0.05
-91.80%
-0.72
22.03%
-0.63
12.50%
-0.54
1.89%
-0.61
1.67%
-0.59
22.92%
-0.56
60.00%
-0.53
60.61%
-0.60
-67.57%
-0.48
92.00%
-0.35
-0.33
560.00%
-1.85
6066.67%
-0.25
733.33%
-0.05
-0.03
-0.03
EPS - Diluted
-0.64
1.59%
0.38
-170.37%
-0.05
-91.80%
-0.72
22.03%
-0.63
12.50%
-0.54
1.89%
-0.61
1.67%
-0.59
22.92%
-0.56
60.00%
-0.53
60.61%
-0.60
-67.57%
-0.48
92.00%
-0.35
-0.33
560.00%
-1.85
6066.67%
-0.25
733.33%
-0.05
-0.03
-0.03
EBIT
-65.33M
9.77%
29.64M
-157.61%
-114.81M
133.09%
-66.77M
45.60%
-59.52M
39.24%
-51.44M
29.57%
-49.25M
34.14%
-45.86M
65.26%
-42.74M
94.51%
-39.70M
106.33%
-36.72M
137.83%
-27.75M
72.50%
-21.98M
-19.24M
440.33%
-15.44M
568.64%
-16.09M
809.33%
-3.56M
-2.31M
-1.77M
EBITDA
-64.71M
8.75%
30.24M
-158.80%
-114.49M
132.48%
-66.74M
45.57%
-59.50M
39.26%
-51.43M
29.66%
-49.25M
34.14%
-45.85M
65.27%
-42.73M
94.48%
-39.66M
106.19%
-36.71M
137.87%
-27.74M
72.51%
-21.97M
-19.24M
440.94%
-15.43M
569.88%
-16.08M
809.04%
-3.56M
-2.30M
-1.77M
Depreciation Depletion & Amortization
624.00K
4700.00%
602.00K
5372.73%
313.00K
5116.67%
23.00K
283.33%
13.00K
-13.33%
11.00K
-69.44%
6.00K
0.00%
6.00K
0.00%
15.00K
200.00%
36.00K
620.00%
6.00K
20.00%
6.00K
20.00%
5.00K
5.00K
0.00%
5.00K
0.00%
5.00K
5.00K
5.00K
0.00

DAWN FAQs

What is DAWN's PE Ratio in 2025/4/4?

DAWN's PE ratio in April 4, 2025 is -7.05. This indicates the price investors are willing to pay for $1 of earnings.

What is DAWN's PS Ratio in 2025/4/4?

What is DAWN's Dividend Yield in 2024/Q4?

What is DAWN's Gross Margin in 2024/Q4?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is DAWN earnings result positive or negative?How should I trade on DAWN earnings?